IL1A and neoplasm: Both IL‐1α and IL‐1β are able to increase secretion of SASP factors such as IL‐6 and IL‐8, which have known oncogenic properties [7, 28, 29], and IL‐1α inactivation in senescent cells impairs tumour progression [28].